Clinical trials
catalyst calendar across sponsors →Studies where KRMD is the lead sponsor, as filed with ClinicalTrials.gov. Completion dates are the sponsor's own projected windows and are revised as a study runs. Active studies first, then completed and stopped — newest readout first within each.
1 interventional
Held by 7 tracked-famous managers (Qube Research & Technologies Ltd, RENAISSANCE TECHNOLOGIES LLC, Squarepoint Ops LLC, CITADEL ADVISORS LLC, MARSHALL WACE, LLP, +2 more) · FINRA short interest 5.5 days to cover (settled 2026-07-31) · insider 90d: 2 buys / 0 sells · government filings 180d: none disclosed
| Study | Phase | Status | Interventions | Conditions | Enrollment | Primary completion | Updated |
|---|---|---|---|---|---|---|---|
| Assessing Patient Preference for Infusion SystemsNCT07189013Change in Patient Satisfaction Scores Between Electronic and Mechanical Infusion Pumps Measured on a 5-Point Likert Scale Over 3 MonthsOpen-label · Treatment | Not applicable | Not yet recruiting | Device: Mechanical infusion pump | Primary Immunodeficiencies (PID), Secondary Immunodeficiencies (SID) | 52 | Mar 2026 | 2025-09-23 |
Primary completion is the date the sponsor filed with the registry — their own projection, revised whenever they revise it, unless the row is marked actual.
Source: ClinicalTrials.gov, retrieved 2026-08-19